Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 4Breast Neoplasms 4Neoplasms 3Leiomyoma 2Vomiting 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Periampullary Carcinoma Nos 1Pediatric Crohn's disease 1Pain 1Obesity 1Nausea 1Myasthenia Gravis 1Motor Activity 1Menstruation Disturbances 1Memory Disorders 1Hyperinsulinism 1Hyperandrogenism 1Hot Flashes 1Fatigue 1Cognitive Dysfunction 1Cancer Pain 1Anemia 1

Interventions

Methylphenidate 7Modafinil 4Therapeutics 3Exercise 3Acupuncture Therapy 3Surveys and Questionnaires 2Radiotherapy 2Counseling 2Carnitine 2testosterone enanthate 1testosterone 17 beta-cypionate 1exemestane 1Valeriana extract 1Triptorelin Pamoate 1Testosterone 1Taxes 1Tamoxifen 1Sugars 1Relaxation Therapy 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Psychiatric Rehabilitation 1Paclitaxel 1Mental Status and Dementia Tests 1Materia Medica 1Infliximab 1Hypericum extract LI 160 1Gonadotropin-Releasing Hormone 1Escitalopram 1Epoetin Alfa 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Fatigue × Sugars × Clear all
NCT05041946 2022-09-29

Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial

M.D. Anderson Cancer Center

Phase 3 Completed
112 enrolled

Fatigue, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡